Blueshift Asset Management’s Boston Scientific BSX Stock Holding History

Blueshift Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$527K	Buy	12,347 +3,327	+37%	+$181K	0.12%	191
2026 Q1	$566K	Buy	9,020 +1,637	+22%	+$131K	0.17%	172
2025 Q4	$704K	Buy	7,383 +2,007	+37%	+$197K	0.2%	140
2025 Q3	$525K	Buy	+5,376	New	+$557K	0.16%	180
2022 Q3	–	Sell	-6,614	Closed	-$247K	–	612
2022 Q2	$247K	Buy	+6,614	New	+$269K	0.04%	509
2021 Q3	–	Sell	-35,645	Closed	-$1.52M	–	1026
2021 Q2	$1.52M	Sell	35,645 -15,545	-30%	-$654K	0.08%	265
2021 Q1	$1.98M	Buy	+51,190	New	+$1.94M	0.2%	131
2020 Q4	–	Sell	-63,312	Closed	-$2.42M	–	702
2020 Q3	$2.42M	Buy	63,312 +13,355	+27%	+$515K	0.33%	86
2020 Q2	$1.75M	Buy	+49,957	New	+$1.8M	0.28%	111
2020 Q1	–	Sell	-7,483	Closed	-$338K	–	247
2019 Q4	$338K	Sell	7,483 -99,432	-93%	-$4.16M	0.04%	566
2019 Q3	$4.35M	Buy	+106,915	New	+$4.53M	0.66%	19
2019 Q2	–	Sell	-21,695	Closed	-$833K	–	728
2019 Q1	$833K	Buy	+21,695	New	+$829K	0.12%	280

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Blueshift Asset Management's BSX Position: Q2 2026 in Review

Blueshift Asset Management increased its Boston Scientific (BSX) stake by 37% in Q2 2026, buying an estimated $181K and bringing the position to 12,347 shares worth $527K. The position accounts for 0.12% of the portfolio, ranked #191.

Blueshift Asset Management first reported a position in BSX in Q1 2019 and has held it in 12 quarters since. The position peaked at $4.35M in Q3 2019. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Blueshift Asset Management held 12,347 shares of Boston Scientific worth $527K as of Q2 2026.
Blueshift Asset Management bought 3,327 Boston Scientific shares in Q2 2026, an estimated $181K.
Boston Scientific made up 0.12% of Blueshift Asset Management's portfolio in Q2 2026, its #191 holding.
Blueshift Asset Management first reported a position in Boston Scientific in Q1 2019 and has held it in 12 quarters since.
Blueshift Asset Management's Boston Scientific position peaked at $4.35M in Q3 2019.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.